Welcome to LookChem.com Sign In|Join Free
  • or
[S,R]-(3-ACETYL-2,2-DIMETHYL-CYCLOBUTYL)-CARBAMIC ACID TERT-BUTYL ESTER is a chemical compound characterized by its molecular formula C14H23NO4. It is a tert-butyl ester derivative of carbamic acid, known for its role in organic synthesis and medicinal chemistry. This chiral molecule features two stereocenters, denoted as S and R, which makes it valuable in the study and development of chiral drug molecules and as a reagent in asymmetric synthesis. Its significance extends to the field of organic chemistry, where it is utilized as a building block for the synthesis of complex organic molecules and contributes to the research and development of new pharmaceutical compounds.

188918-44-7

Post Buying Request

188918-44-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

188918-44-7 Usage

Uses

Used in Pharmaceutical Industry:
[S,R]-(3-ACETYL-2,2-DIMETHYL-CYCLOBUTYL)-CARBAMIC ACID TERT-BUTYL ESTER is used as a key intermediate for the synthesis of various pharmaceutical compounds. Its chiral nature allows for the development of enantiomerically pure drugs, which is crucial in ensuring the desired therapeutic effects and minimizing potential side effects.
Used in Organic Synthesis:
In the field of organic chemistry, [S,R]-(3-ACETYL-2,2-DIMETHYL-CYCLOBUTYL)-CARBAMIC ACID TERT-BUTYL ESTER serves as a versatile building block for the creation of complex organic molecules. Its unique structure and reactivity make it a valuable component in the synthesis of a wide range of organic compounds.
Used in Medicinal Chemistry:
[S,R]-(3-ACETYL-2,2-DIMETHYL-CYCLOBUTYL)-CARBAMIC ACID TERT-BUTYL ESTER is employed as a reagent in asymmetric synthesis, which is essential for the development of chiral drug molecules. The ability to produce enantiomerically pure compounds is vital in medicinal chemistry, as the different enantiomers of a drug can have distinct biological activities and pharmacological properties.
Used in Research and Development:
This chemical compound is also utilized in the research and development of new drugs. Its involvement in the synthesis of complex organic molecules and its role in asymmetric synthesis make it a valuable tool for scientists and researchers working on the discovery and development of novel pharmaceutical agents.

Check Digit Verification of cas no

The CAS Registry Mumber 188918-44-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,8,9,1 and 8 respectively; the second part has 2 digits, 4 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 188918-44:
(8*1)+(7*8)+(6*8)+(5*9)+(4*1)+(3*8)+(2*4)+(1*4)=197
197 % 10 = 7
So 188918-44-7 is a valid CAS Registry Number.

188918-44-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name [S,R]-(3-ACETYL-2,2-DIMETHYL-CYCLOBUTYL)-CARBAMIC ACID TERT-BUTYL ESTER

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:188918-44-7 SDS

188918-44-7Relevant academic research and scientific papers

1,3,4-OXADIAZOLONE COMPOUND AND MEDICINE

-

Paragraph 0336; 0409; 0413, (2021/09/24)

The purpose of the present invention is to provide a compound having PIM inhibitory activity. Examples of the present invention include 1,3,4-oxadiazolone compounds represented by the following formula [1], and pharmaceutically acceptable salts, and solvates thereof. The compounds of the present invention have PIM inhibitory activity. In addition, since the compounds of the present invention have PIM inhibitory activity, the compounds of the present invention are useful as therapeutic agents for systemic lupus erythematosus, lupus nephritis, etc.

Chiral 1,3-cyclobutane amino acids: Syntheses and extended conformations

Burgess, Kevin,Li, Shiming,Rebenspies, Joe

, p. 1681 - 1684 (2007/10/03)

Optically active samples of the N-protected 1,3-cyclobutane amino acids 1 and 2 were prepared from α-pinene. The synthesis of 1 is enantiodivergent insofar as both optical antipodes of the product can be prepared from the same α-pinene enantiomer. Single crystal X-ray diffraction studies of derivatives of 1 reveal these compounds can have extended conformations.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 188918-44-7